#1 Clinical Trials Search in Europe

Tapentadol Hydrochloride

This article examines the use of Tapentadol Hydrochloride in clinical trials for managing various types of pain. Tapentadol is a centrally-acting analgesic with a dual mechanism of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition. Clinical studies have investigated its effectiveness for conditions like postoperative pain, osteoarthritis, low back pain, and cancer-related pain. The trials assess Tapentadol’s efficacy, safety, and tolerability compared to placebo and other pain medications.

Table of Contents

What is Tapentadol Hydrochloride?

Tapentadol hydrochloride is a prescription medication used to treat moderate to severe pain. It is known by the brand names Nucynta and Palexia[5]. Tapentadol is a centrally acting analgesic, which means it works in the brain and spinal cord to reduce pain signals[2].

What makes tapentadol unique is its dual mechanism of action. It works as both a mu-opioid receptor agonist (similar to traditional opioids) and a norepinephrine reuptake inhibitor. This combination allows it to effectively relieve pain while potentially causing fewer side effects than traditional opioids[1].

What Conditions Does Tapentadol Treat?

Tapentadol is used to treat various types of moderate to severe pain, including:

  • Chronic pain: Long-lasting pain that persists for months or years[3]
  • Low back pain: Pain in the lower back area, which can be acute or chronic[5]
  • Osteoarthritis pain: Pain caused by wear and tear of joints, particularly in the knee[3]
  • Neuropathic pain: Pain caused by damage or dysfunction of the nervous system[6]
  • Postoperative pain: Pain following surgical procedures, such as bunionectomy (foot surgery)[2]
  • Cancer pain: Pain related to cancer or its treatment[7]

How Does Tapentadol Work?

Tapentadol works in two main ways to relieve pain:

  1. Mu-opioid receptor agonism: It binds to mu-opioid receptors in the brain and spinal cord, which helps to block pain signals.
  2. Norepinephrine reuptake inhibition: It increases the levels of norepinephrine, a neurotransmitter that helps to reduce pain sensations.

This dual action is believed to contribute to tapentadol’s effectiveness in treating various types of pain while potentially reducing some of the typical opioid-related side effects[1].

Tapentadol Formulations

Tapentadol is available in two main formulations:

  1. Immediate Release (IR): This formulation provides quick pain relief and is often used for acute pain or breakthrough pain episodes[5].
  2. Prolonged Release (PR) or Extended Release (ER): This formulation provides long-lasting pain relief and is typically used for chronic pain conditions. It allows for less frequent dosing, usually twice daily[4].

Dosing Information

The dosing of tapentadol can vary depending on the specific formulation, the patient’s pain intensity, and their previous opioid experience. Here are some general guidelines:

  • For immediate release tapentadol, doses typically range from 50 mg to 100 mg every 4 to 6 hours[2].
  • For prolonged release tapentadol, starting doses are usually 50 mg twice daily, which can be adjusted upwards as needed[5].
  • The maximum daily dose of tapentadol (combining both IR and PR formulations) should not exceed 500 mg per day[6].

It’s important to note that dosing should always be determined by a healthcare provider based on individual patient needs and response to the medication.

Effectiveness of Tapentadol

Clinical trials have shown tapentadol to be effective in treating various types of pain:

  • In patients with chronic low back pain or osteoarthritis, tapentadol PR significantly reduced pain intensity compared to baseline[5].
  • For postoperative pain following bunionectomy, tapentadol IR provided effective pain relief compared to placebo[2].
  • In cancer pain patients, tapentadol PR was effective in providing sustained pain control[7].

Many studies also assessed patient-reported outcomes, such as quality of life and overall impression of change, which generally showed improvements with tapentadol treatment[4].

Potential Side Effects

Like all medications, tapentadol can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Constipation
  • Dizziness
  • Drowsiness
  • Headache

However, due to its dual mechanism of action, tapentadol may cause fewer opioid-related side effects compared to traditional opioids[1]. It’s important to discuss any side effects with your healthcare provider.

Comparisons to Other Pain Medications

Several studies have compared tapentadol to other pain medications:

  • Tapentadol has been compared to oxycodone in various pain conditions, often showing similar efficacy with potentially fewer side effects[2].
  • In some studies, tapentadol has been compared to morphine, fentanyl, and buprenorphine, with researchers calculating equivalent doses for pain relief[6].
  • Tapentadol has also been compared to non-opioid pain relievers like paracetamol (acetaminophen) for postoperative pain management[1].

These comparisons help healthcare providers determine the most appropriate pain management strategy for individual patients.

Aspect Details
Drug Name Tapentadol Hydrochloride
Mechanism of Action Dual action: mu-opioid receptor agonist and norepinephrine reuptake inhibitor
Formulations Studied Immediate Release (IR) and Prolonged Release (PR) tablets
Pain Conditions Postoperative pain, Osteoarthritis, Chronic low back pain, Cancer-related pain
Key Outcome Measures Pain intensity, Physical function, Quality of life, Global impression of change
Comparators Placebo, Oxycodone, Paracetamol (Acetaminophen)
Safety Assessments Adverse events, Tolerability, Laboratory tests, Vital signs
Dosing Strategy Typically twice daily, with dose adjustments based on efficacy and tolerability
Special Populations Studies include opioid-naive and opioid-experienced patients
Additional Assessments Sleep quality, Anxiety and depression scales, Neuropathic pain components

FAQ

  • What is Tapentadol Hydrochloride? Tapentadol Hydrochloride is a centrally-acting analgesic medication with a dual mechanism of action. It works as both a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor, providing pain relief through two different pathways in the body.
  • What types of pain conditions are being studied with Tapentadol? Clinical trials are investigating Tapentadol's effectiveness for various pain conditions, including postoperative pain (e.g. after bunionectomy surgery), osteoarthritis pain (particularly knee osteoarthritis), chronic low back pain, and cancer-related pain.
  • How is Tapentadol administered in these trials? Tapentadol is typically administered orally in these trials. It comes in different formulations, including immediate release (IR) and prolonged release (PR) tablets. The dosing regimens vary by study, but often involve taking the medication twice daily, with doses adjusted as needed for pain relief and tolerability.
  • What are some of the main outcomes being measured in Tapentadol trials? Key outcomes being assessed include changes in pain intensity (often measured on numerical rating scales), improvements in physical function, quality of life measures, patient and clinician global impressions of change, and assessments of drug safety and tolerability.
  • How does Tapentadol compare to other pain medications in these studies? Some trials compare Tapentadol to placebo, while others use active comparators like oxycodone or paracetamol (acetaminophen). The studies aim to determine if Tapentadol provides equivalent or superior pain relief with potentially fewer side effects compared to existing treatments.

Ongoing Clinical Trials on Tapentadol Hydrochloride

  • Study on Preventing Chronic Pain After Hernia and Knee Surgery Using Tapentadol for Patients Undergoing These Surgeries

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Analgesic: A medication used to relieve pain.
  • Mu-opioid receptor agonist: A substance that binds to and activates mu-opioid receptors in the body, which are involved in pain signaling and relief.
  • Norepinephrine reuptake inhibitor: A substance that blocks the reabsorption of the neurotransmitter norepinephrine in the brain, potentially enhancing its pain-relieving effects.
  • Osteoarthritis: A type of arthritis characterized by the breakdown of joint cartilage and underlying bone, often causing pain and stiffness.
  • Bunionectomy: A surgical procedure to remove or correct a bunion, which is a bony bump that forms on the joint at the base of the big toe.
  • Prolonged release (PR): A medication formulation designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Immediate release (IR): A medication formulation that releases the active ingredient quickly after administration.
  • Numerical Rating Scale (NRS): A pain assessment tool where patients rate their pain intensity on a scale, typically from 0 (no pain) to 10 (worst pain imaginable).
  • Quality of life: A measure of an individual's overall well-being and ability to function in daily life, often assessed in pain studies.
  • Titration: The process of gradually adjusting the dose of a medication to find the optimal balance between effectiveness and side effects.
  • Neuropathic pain: Pain caused by damage or disease affecting the nervous system.
  • WHO Step I, II, III analgesics: A classification system for pain medications developed by the World Health Organization, ranging from non-opioid analgesics (Step I) to strong opioids (Step III).

References

  1. https://clinicaltrials.gov/study/NCT05999890
  2. https://clinicaltrials.gov/study/NCT00806247
  3. https://clinicaltrials.gov/study/NCT00745069
  4. https://clinicaltrials.gov/study/NCT00983073
  5. https://clinicaltrials.gov/study/NCT00983385
  6. https://clinicaltrials.gov/study/NCT00986258
  7. https://clinicaltrials.gov/study/NCT00805142